M. Minhaj Siddiqui, MD; Soroush Rais-Bahrami, MD; Baris Turkbey, MD; et al.
This cohort study reports that targeted magnetic resonance/ultrasound fusion biopsy, compared with standard extended-sextant ultrasound-guided biopsy, was associated with increased detection of high-risk prostate cancer and decreased detection of low-risk prostate cancer among men undergoing biopsy for suspected prostate cancer.